Brief: Devyser Expands Commercial Agreement With Thermo Fisher Scientific
June 17 (Reuters) - Devyser Diagnostics AB DVYSR.ST :
* ANNOUNCES EXPANDED COMMERCIAL AGREEMENT WITH THERMO FISHER
SCIENTIFIC FOR POST-TRANSPLANT MONITORING NGS PRODUCTS
* DEAL GIVES THERMO FISHER EXCLUSIVE RIGHTS TO
COMMERCIALIZE,
UNDER COMBINED BRANDS, DEVYSER'S POST-TRANSPLANT PORTFOLIO OF
NGS PRODUCTS GLOBALLY
Source text for Eikon: ID:nMFN5bXpsP
Further company coverage: DVYSR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Devyser Diagnostics AB
See all newsBrief: Devyser Awarded Tender In Italy Valued At SEK 8.9 Million
Brief: Devyser Diagnostics Appoints Niklas Axelsson As CFO
Sweden's Devyser Q1 net sales rise 12.9%, operating profit turns positive
Brief: Devyser Q1 Sales SEK 61.8 Million
Brief: Devyser Completes Cybergene Acquisition, Carries Out Compensation Share Issue